Study of oral Mifepristone as a cervical ripening agent to induce labour in low-risk full-term live pregnancy beyond 40 weeks of gestation.

Study of oral Mifepristone as a cervical ripening agent to induce labour in low-risk full-term live pregnancy beyond 40 weeks of gestation - a randomized controlled trial - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2024/02/062460

Enrollment

100

Registered

2024-02-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: Tab Mifepristone: We will give Tab Mifepristone 200mg orally 2 doses 24 hours apart and wait till 72 hours from the first dose for Bishop score to improve Control Intervention1: Expecta

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant females of age between 18-45 years old, Primigravida or Gravida 2, with singleton live pregnancy with cephalic presentation of gestational age 40-41 weeks without any obstetric complications, having an unripe cervix and intact membranes.

Exclusion criteria

Exclusion criteria: Pregnant females having any obstetric complications, any previous uterine surgery, any fetal compromise.

Design outcomes

Primary

Measure	Time frame
Gain in Bishops score Timepoint: Baseline, at 24 hours, 48 hours, 72 hours from first dose of Mifepristone	—

Secondary

Measure	Time frame
1)Duration of induction to active phase of labour & induction to delivery interval. 2)Mode of delivery 3)Maternal & perinatal complications Timepoint: 1) When women enters active stage of labour & when she delivers 2) At delivery 3) At delivery	—

Countries

India

Contacts

Public ContactDr. Hanslata Gehlot

Umaid Hospital, Dr. S.N. Medical College, Jodhpur

pummyia@gmail.com09414135070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026